Carlos Grilo, PhD, Professor of Psychiatry and of Psychology and Director of the Yale Program for Obesity Weight and Eating Research, recently served as guest co-editor on a special issue of Clinical Therapeutics, centered around the topic of eating disorders.
Grilo co-authored the following articles in the January 2021 special issue:
- Eating Disorders Update 2021: What We Know, What We Don't Know, and Next Steps
- Psychotherapy and Medications for Eating Disorders: Better Together?
- The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics
Grilo was also the lead author of a study evaluating the effects of naltrexone + bupropion (NB) on binge-eating disorder with obesity, and the longer-term effects through 6-month follow-up after the discontinuation of medication. The article is titled, "Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study."
Submitted by Jordan Sisson on February 23, 2021